ConductScience.org, home

Paper6794841

The six disease of WHO.

Waters MF. Br Med J (Clin Res Ed), 1981. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. The six disease of WHO. Papers, record 6794841. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6794841

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The six disease of WHO.
PubMed
Journal
Br Med J (Clin Res Ed)
PubMed
Year
1981
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.24
iCite
Revised in PubMed
2019-05-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Waters MFM F

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LeprosyMajor topic
Adult
Animals
Dapsone
Drug Administration Schedule
Drug Resistance, Microbial
Humans
Mycobacterium leprae
Rifampin
Time Factors

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114492126A classification of leprosy for research purposes.Lepr Rev1962https://conductscience.org/library/papers/14492126PubMed
2392212Dapsone-resistant leprosy in Ethiopia.Lepr Rev1979https://conductscience.org/library/papers/392212PubMed
314445823Acid-fast bacilli in nasal excretions in leprosy, and results of inoculation of mice.Am J Hyg1960https://conductscience.org/library/papers/14445823PubMed
45950347Classification of leprosy according to immunity. A five-group system.Int J Lepr Other Mycobact Dis1966https://conductscience.org/library/papers/5950347PubMed
54860661Experimental lepromatous leprosy.Nature1967https://conductscience.org/library/papers/4860661PubMed
64877714The death of Mycobacterium leprae during treatment with 4,4'-diaminodiphenylsulfone (DDS). Initial rate in patients.Am J Trop Med Hyg1968https://conductscience.org/library/papers/4877714PubMed
74903972Experimental and clinical studies on rifampicin in treatment of leprosy.Br Med J1970https://conductscience.org/library/papers/4903972PubMed
84945738Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.Clin Exp Immunol1971https://conductscience.org/library/papers/4945738PubMed
94554496Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.Am J Trop Med Hyg1972https://conductscience.org/library/papers/4554496PubMed
104948218Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo.Int J Lepr Other Mycobact Dis1971https://conductscience.org/library/papers/4948218PubMed
114559066Rapid bactericidal effect of rifampin on Mycobacterium leprae.Am J Trop Med Hyg1972https://conductscience.org/library/papers/4559066PubMed
124613977Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli.Lepr Rev1974https://conductscience.org/library/papers/4613977PubMed
1349662Sulphone resistance in leprosy. A review of one hundred proven clinical cases.Lancet1975https://conductscience.org/library/papers/49662PubMed
14776852Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.Int J Lepr Other Mycobact Dis1976https://conductscience.org/library/papers/776852PubMed
15959886Leprosy in the United States, 1950-1969: an epidemiologic review.South Med J1976https://conductscience.org/library/papers/959886PubMed
1663780Rifampin-resistant leprosy.Lancet1976https://conductscience.org/library/papers/63780PubMed
17339995Rifampicin for lepromatous leprosy: nine years' experience.Br Med J1978https://conductscience.org/library/papers/339995PubMed
1814188912SULPHONE RESISTANCE IN LEPROSY. AN EXPERIMENTAL AND CLINICAL STUDY.Lancet1964https://conductscience.org/library/papers/14188912PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn Papers
36684586SARS-CoV-2 Spike protein activates TMEM16F-mediated platelet procoagulant activity.Front Cardiovasc Med2022https://conductscience.org/library/papers/36684586

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6794841

GET https://conductscience.org/api/papers/v1/6794841/authors